Saturday, January 05, 2008

The real story behind the ephedrine ban?

Now that isn't a whole lot of money. But Tucker argues that lobbying by Boehringer-Ingelheim went up dramatically at about the same time the pseudoephedrine ban -- also known as the Combat Methamphetamine Epidemic Act of 2005 -- was placed as a rider in the Patriot Act reauthorization. Coincidence?

No comments: